Is NASDAQ:AZN suited for quality investing?

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if ASTRAZENECA PLC-SPONS ADR (NASDAQ:AZN) is suited for quality investing. Investors should of course do their own research, but we spotted ASTRAZENECA PLC-SPONS ADR showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

Why NASDAQ:AZN may be interesting for quality investors.

• The 5-year revenue growth of ASTRAZENECA PLC-SPONS ADR has been remarkable, with 17.27% increase. This showcases the company's strong performance in driving revenue growth and indicates its competitiveness within the market.
• With a notable ROIC excluding cash and goodwill at 84.56%, ASTRAZENECA PLC-SPONS ADR demonstrates its commitment to generating sustainable returns for shareholders. This metric emphasizes the company's effective use of capital and its ability to deliver long-term value.
• The Debt/Free Cash Flow Ratio of ASTRAZENECA PLC-SPONS ADR stands at 4.16, reflecting the company's prudent capital structure and cash flow dynamics. This ratio highlights the company's ability to generate robust free cash flow relative to its debt obligations.
• ASTRAZENECA PLC-SPONS ADR demonstrates consistent Profit Quality over the past 5 years, with a strong 772.0%. This indicates the company's ability to generate sustainable and reliable profits, showcasing its long-term profitability and financial stability.
• ASTRAZENECA PLC-SPONS ADR has experienced impressive EBIT growth over the past 5 years, with 27.53% increase. This reflects the company's effective operational performance and highlights its potential for long-term financial success.
• ASTRAZENECA PLC-SPONS ADR has achieved superior EBIT 5-year growth compared to its Revenue 5-year growth. This demonstrates the company's ability to maximize its profitability through effective cost management and operational strategies.

Zooming in on the fundamentals.

ChartMill employs a sophisticated system to assign a Fundamental Rating to every stock in its analysis. This rating, which ranges from 0 to 10, is determined by carefully assessing multiple fundamental indicators and properties.

Overall AZN gets a fundamental rating of 6 out of 10. We evaluated AZN against 195 industry peers in the Pharmaceuticals industry. While AZN has a great profitability rating, there are some minor concerns on its financial health. AZN is valued quite cheap, while showing a decent growth score. This is a good combination!

For an up to date full fundamental analysis you can check the fundamental report of AZN

Our Caviar Cruise screen will find you more ideas suited for quality investing.

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.